These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13269946)

  • 1. Use of anirrit in the treatment of epilepsy.
    ROBINSON PK
    Br Med J; 1956 Jan; 1(4957):28. PubMed ID: 13269946
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of epilepsy with anirrit].
    JANZ D
    Nervenarzt; 1953 May; 24(5):208-13. PubMed ID: 13099435
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the therapy of epilepsy with Anirrit Berna].
    Mamoli A
    Riv Neurobiol; 1971; 17(3):226-37. PubMed ID: 5156124
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of epilepsy with a hydantion product "anirrit" (hydantoin bromate)].
    BOCCI U; INGA EF
    Minerva Med; 1959 Nov; 50():3572-5. PubMed ID: 13801846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Medical significance of the hydantoins].
    SROKA K
    Klin Med Osterr Z Wiss Prakt Med; 1953 Apr; 8(4):171-8. PubMed ID: 13085651
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesantoin in the treatment of epilepsy.
    WISE RA; HEUMANN WA
    Psychiatr Q; 1955 Jul; 29(3):403-11. PubMed ID: 13266919
    [No Abstract]   [Full Text] [Related]  

  • 7. [3-Methyl-5, 5-phenylethylhydantoin therapy of epilepsy].
    DONATI A; BERNARDI L
    Rass Studi Psichiatr; 1952; 41(6):1171-92. PubMed ID: 13047632
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of epilepsy with mesantoin].
    HALLEN O
    Munch Med Wochenschr; 1953 Aug; 95(34):913-4. PubMed ID: 13087111
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of epilepsy with mesantoin].
    HALLEN O
    Munch Med Wochenschr; 1953 Aug; 95(35):963-5; concl. PubMed ID: 13087132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of epilepsy with bagrosin-sodium].
    KOSLOWSKY HG
    Med Klin; 1957 Dec; 52(49):2128-9. PubMed ID: 13503578
    [No Abstract]   [Full Text] [Related]  

  • 11. [The value of 3-methyl 5.5. phenylethylhydantoin in therapy of epilepsy].
    HOLTZER PA
    Geneeskd Gids; 1952 May; 30(9):181-7. PubMed ID: 14955069
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical treatment of epilepsy.
    FORSTER FM
    Acta Med Philipp; 1952; 9(2):93-100. PubMed ID: 13065013
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of mesantoin therapy of epilepsy].
    KLOPP HW
    Med Monatsschr; 1951 Nov; 5(11):779-82. PubMed ID: 14910242
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuvarone (3-methyl-5, phenylhydantoin) in the treatment of epilepsy.
    TATERKA JH; THOMPSON CB
    Dis Nerv Syst; 1953 Apr; 14(4):108-10. PubMed ID: 13052037
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Mesantoin in epilepsy].
    PRADO-HUANTE H
    Medicina (Mex); 1956 May; 36(748):229-32. PubMed ID: 13347596
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hydantoin therapy in epilepsy].
    STRAUCH W
    Dtsch Gesundheitsw; 1953 May; 8(20):591-601. PubMed ID: 13067813
    [No Abstract]   [Full Text] [Related]  

  • 17. ANTICONVULSANT drugs in epilepsy.
    Med World; 1952 Jul; 76(18):489. PubMed ID: 14947377
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesantoin in the control of epilepsy.
    LOSCALZO AE
    Neurology; 1952; 2(5):403-11. PubMed ID: 14957213
    [No Abstract]   [Full Text] [Related]  

  • 19. Phelantin for the treatment of epilepsy.
    DAVIDSON DT; BERMAN BA
    J Am Med Assoc; 1956 Mar; 160(9):766-8. PubMed ID: 13286131
    [No Abstract]   [Full Text] [Related]  

  • 20. [Benefits and adverse effects of methyl-phenyl-ethyl-hydantoin in the treatment of epilepsy].
    NEHLIL J
    Presse Med (1893); 1954 May; 62(36):760-1. PubMed ID: 13177463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.